Monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase
Abstract:
Provided is a monoclonal antibody or a fragment thereof that selectively inhibits the enzymatic activity of vascular endothelial lipase and pharmaceutical compositions containing the same as an active ingredient useful for the treatment of arteriosclerosis or metabolic syndrome.
Information query
Patent Agency Ranking
0/0